NHS duty to finance proven cancer therapies

Sean Duffy, National Clinical Director for Cancer, NHS England had a letter published in yesterday’s Sunday Times. He wrote:  “Although medical evidence shows that stereotactic ablative body radiotherapy (SABR) can be effective for non-small-cell lung cancer — and NHS England routinely funds this — there is a lack of good research evidence that SABR is effective for other cancers.

Sunday Times